Your PDC is read by payers, accreditors, and manufacturers alike, and your LDD designations depend on patient management you can document. QliqSOFT automates the outreach, scores every assessment, and captures the data trail that keeps you in the network and on the panel.
Specialty drugs will pass half of all U.S. drug spending by 2030, and the pharmacies that capture that growth are the ones whose adherence, service, and data hold up in front of payers, accreditors, and manufacturers at once.
Proportion of days covered and MPR are used by payers, accrediting bodies, and manufacturers to compare pharmacies. Every late fill and every quiet discontinuation shows up in the number your contracts are judged on.
382 drugs sit in limited distribution; 68% of those networks hold four pharmacies or fewer. LDD contracts dictate outreach cadence, education, and data collection, documented performance is what keeps the designation.
PBM-owned specialty pharmacies hold roughly two-thirds of dispensing revenue. Independents win on the things scale can’t fake: patient management, responsiveness, and accreditation, URAC and ACHC gate the networks themselves.
Every one of these is a communication problem in disguise. That’s the problem we solve.
The phone-based refill model is the most expensive process in your building: techs making three attempts per patient per cycle, shipments waiting on voicemails, and clinicians dialing healthy patients while struggling ones go quiet. Quincy sends a scored assessment ahead of every fill, and the score does the classification the instant the patient taps submit.
Patients don’t discontinue at the pharmacy counter, they fade out at home: a side effect nobody managed, a copay nobody navigated, a regimen nobody explained twice. Structured engagement through the first 90 days and every cycle after keeps patients on therapy and keeps your adherence numbers worth showing.
LDD contracts spell out how often you reach patients, what you teach them, and what you collect, and the quarterly business review is where designations are kept or lost. When outreach, education, and assessments run through one platform, the reporting your manufacturers and payers demand assembles itself.
Specialty patients live with therapies that don’t keep business hours, and a scared oncology patient who reaches voicemail stops therapy or lands in an ER. Our AI voice agents answer every after-hours call, capture the full picture, and route the caller to the right available expert using your live QliqSOFT on-call schedule.
URAC and ACHC accreditation gate your PBM networks. Manufacturer contracts gate your LDDs. Payer audits gate your reimbursement. All three ask the same question: can you document your patient management program?
Accreditation and contract references summarized for marketing purposes, have compliance counsel review final claims before publication.
QliqCHAT keeps pharmacists, techs, and liaisons in sync while Quincy keeps patients onboarded, assessed, and on therapy, one connected system that serves the patient and builds your book of evidence.
Referrals answered day or night, routed to on-call intake; enrollment forms e-signed the same day.
AI Voice + QuincyStatus updates flow to patient and prescriber; financial assistance enrolled before sticker shock.
QuincyOnboarding education, delivery confirmation, and a day-3 check-in, the first 90 days, defended.
Quincy + QliqCHATScored refill assessments triage every patient; side-effect escalations reach the pharmacist in minutes.
Quincy → QliqCHATA rising PDC, documented outreach, and QBRs that assemble in hours, access earned again.
The Whole PlatformIllustrative role composites drawn from real customer conversations, not attributed quotes. Named, verified customer results and quotes appear throughout this site.
Refill calls dropped by three-quarters and our fills go out faster. The high-score flags find the patients who actually need a pharmacist.
Our PDC on two key therapies moved enough to show up in payer scorecards. That’s contract leverage we’ve never had before.
Our last manufacturer QBR took a morning to prepare instead of two weeks. Every outreach touchpoint was already time-stamped.
Patients tell the forms things they never told our techs on the phone. We intercept discontinuations we didn’t know were happening.
Run more than one line? See how multi-service line organizations use one platform →
In a 30-minute demo mapped to your pharmacy, scored refill assessments, adherence engagement, after-hours coverage, manufacturer reporting, we’ll show you exactly where the calls stop and the evidence starts.
Specialty therapies fail in the gaps between refills. Here is one cycle with the gaps closed.
As covered in Pharmacy Times.